BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Patrick MT, Zhang H, Wasikowski R, Prens EP, Weidinger S, Gudjonsson JE, Elder JT, He K, Tsoi LC. Associations between COVID-19 and skin conditions identified through epidemiology and genomic studies. J Allergy Clin Immunol 2021;147:857-869.e7. [PMID: 33485957 DOI: 10.1016/j.jaci.2021.01.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Smith-Norowitz TA, Shidid S, Hammerschlag MR, Kohlhoff S. Rates of SARS-CoV-2 infection in paediatric patients with atopic dermatitis or asthma in Brooklyn, New York. Acta Paediatr 2022;111:602-3. [PMID: 34850447 DOI: 10.1111/apa.16203] [Reference Citation Analysis]
2 Kado S, Kamiya K, Kishimoto M, Maekawa T, Kuwahara A, Sugai J, Komine M, Ohtsuki M. Single-center survey of biologic use for inflammatory skin diseases during the coronavirus disease 2019 pandemic. J Dermatol 2021;48:1907-12. [PMID: 34549456 DOI: 10.1111/1346-8138.16159] [Reference Citation Analysis]
3 Zhu Z, Zhang S, Wang P, Chen X, Bi J, Cheng L, Zhang X. A comprehensive review of the analysis and integration of omics data for SARS-CoV-2 and COVID-19. Brief Bioinform 2021:bbab446. [PMID: 34718395 DOI: 10.1093/bib/bbab446] [Reference Citation Analysis]
4 D'Agostino I, Mathew GE, Angelini P, Venanzoni R, Angeles Flores G, Angeli A, Carradori S, Marinacci B, Menghini L, Abdelgawad MA, Ghoneim MM, Mathew B, Supuran CT. Biological investigation of N-methyl thiosemicarbazones as antimicrobial agents and bacterial carbonic anhydrases inhibitors. J Enzyme Inhib Med Chem 2022;37:986-93. [PMID: 35322729 DOI: 10.1080/14756366.2022.2055009] [Reference Citation Analysis]
5 Gu X, Chen X, Shen M. Association of psoriasis with risk of COVID-19: A 2-sample Mendelian randomization study. J Am Acad Dermatol 2022:S0190-9622(22)00200-6. [PMID: 35131400 DOI: 10.1016/j.jaad.2022.01.048] [Reference Citation Analysis]
6 Helmert C, Siegels D, Haufe E, Abraham S, Heratizadeh A, Kleinheinz A, Harder I, Schäkel K, Effendy I, Wollenberg A, Sticherling M, Stahl M, Worm M, Schwichtenberg U, Schwarz B, Rossbacher J, Buck PM, Schenck F, Werfel T, Weidinger S, Schmitt J; das TREATgermany Studienteam. Wahrnehmung der Corona-Pandemie durch Neurodermitispatienten - Ergebnisse aus dem Neurodermitisregister TREATgermany. J Dtsch Dermatol Ges 2022;20:45-58. [PMID: 35040570 DOI: 10.1111/ddg.14655_g] [Reference Citation Analysis]
7 Rakita U, Kaundinya T, Guraya A, Nelson K, Maner B, Manjunath J, Schwartzman G, Lane B, Silverberg JI. Atopic dermatitis is not associated with SARS-CoV-2 outcomes. Arch Dermatol Res 2021. [PMID: 34533589 DOI: 10.1007/s00403-021-02276-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Kamiya K, Komine M, Ohtsuki M. Biologics for Psoriasis during the COVID-19 Pandemic. J Clin Med 2021;10:1390. [PMID: 33808455 DOI: 10.3390/jcm10071390] [Reference Citation Analysis]
9 Helmert C, Siegels D, Haufe E, Abraham S, Heratizadeh A, Kleinheinz A, Harder I, Schäkel K, Effendy I, Wollenberg A, Sticherling M, Stahl M, Worm M, Schwichtenberg U, Schwarz B, Rossbacher J, Buck PM, Schenck F, Werfel T, Weidinger S, Schmitt J; TREATgermany Study Team. Perception of the coronavirus pandemic by patients with atopic dermatitis - Results from the TREATgermany registry. J Dtsch Dermatol Ges 2021. [PMID: 34958179 DOI: 10.1111/ddg.14655] [Reference Citation Analysis]
10 Diotallevi F, Campanati A, Radi G, Martina E, Rizzetto G, Barbadoro P, D'Errico MM, Offidani A. Vaccines Against SARS-CoV-2 in Psoriasis Patients on Immunosuppressive Therapy: Implications of Vaccination Nationwide Campaign on Clinical Practice in Italy. Dermatol Ther (Heidelb) 2021;11:1889-903. [PMID: 34586598 DOI: 10.1007/s13555-021-00610-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Campanati A, Diotallevi F, Martina E, Radi G, Offidani A. Treatment of Moderate to Severe Psoriasis during the COVID-19 Pandemic: Lessons Learned and Opportunities. J Clin Med 2022;11:2422. [PMID: 35566548 DOI: 10.3390/jcm11092422] [Reference Citation Analysis]
12 Arora H, Boothby-Shoemaker W, Braunberger T, Lim HW, Veenstra J. Safety of conventional immunosuppressive therapies for patients with dermatological conditions and coronavirus disease 2019: A review of current evidence. J Dermatol 2021. [PMID: 34962304 DOI: 10.1111/1346-8138.16182] [Reference Citation Analysis]
13 Fan R, Leasure AC, Damsky W, Cohen JM. Association between atopic dermatitis and COVID-19 infection: A case-control study in the All of Us research program. JAAD Int 2022;6:77-81. [PMID: 34977817 DOI: 10.1016/j.jdin.2021.12.007] [Reference Citation Analysis]
14 Morimoto H, Hayano S, Ozawa N, Ogura Y, Usui H, Usami T, Ohse A, Otsuka M, Miyachi M, Tokura Y. Questionnaire Survey of Possible Association of Allergic Diseases with Adverse Reactions to SARS-CoV-2 Vaccination. Vaccines (Basel) 2021;9:1421. [PMID: 34960167 DOI: 10.3390/vaccines9121421] [Reference Citation Analysis]
15 Rakita U, Kaundinya T, Guraya A, Nelson K, Maner B, Manjunath J, Schwartzman G, Lane B, Silverberg JI. Associations between onychomycosis and COVID-19 clinical outcomes: a retrospective cohort study from a US metropolitan center. Arch Dermatol Res 2021. [PMID: 34773138 DOI: 10.1007/s00403-021-02299-8] [Reference Citation Analysis]
16 Baloghová J, Kampe T, Kolarčik P, Hatalová E. Vaccination, Risk Factors and Outcomes of COVID-19 Infection in Patients with Psoriasis—A Single Centre Real-Life Experience from Eastern Slovakia. Viruses 2022;14:1646. [DOI: 10.3390/v14081646] [Reference Citation Analysis]